Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NantVentures
California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
NantVentures invests in clinical-stage biotechnology companies developing next-generation immunotherapies, gene therapies, and diagnostics. Portfolio companies include ImmunityBio (with 27 clinical trials across 13 indications) and Precision Biologics (with Phase 2a and Phase 2b trials for pancreatic and colorectal cancers).
- Therapeutic areas
- OncologyNeurologyOphthalmologyInfectious Diseases
- Modalities
- AntibodyGene therapyCell therapyVaccineSmall moleculeRecombinant protein
- Industry
- Investors
02
Partnerships
Precision BiologicsBenitec BiopharmaImmunityBioNantWorks ecosystem companies
Beyond the preview
Go deeper on NantVentures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NantVentures.